Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Summary: GLP-1 receptor agonists may indirectly improve psoriasis through weight loss and metabolic benefits, but they are not licensed or recommended as psoriasis treatments in the UK
Nat Rev Endocrinol 112
The STEP trial extensions tracked semaglutide use for three years with consistent safety profiles
compounded tirzepatide injection
Clinical Results: What the Numbers Tell Us In large-scale clinical trials: Semaglutide users lost about 15% of their body weight over 68 weeks in STEP trials
US$ 21.43
US$ 20.62
US$ 26.47
US$ 23.85
US$ 21.08
US$ 28.95
US$ 20.32
US$ 21.72
US$ 29.44
